NEW YORK (GenomeWeb News) – Researchers at The University of Texas, Austin and Southwestern University will use a $730,000 grant from the National Institutes of Health to develop a new method for rapidly screening blood samples for protein biomarkers, UT-Austin said last week.

The three-stage screening method will involve using a chip with capture agents that bind to specific compounds in a blood sample, an ultraviolet light to sever those chemical bonds, and an electrospray that transfers the compounds into a mass spectrometer for analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.